...
首页> 外文期刊>Journal of cardiac surgery. >Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B
【24h】

Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B

机译:血友病A和B患者冠状动脉旁路手术的替代疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract There are only a few cases of patients with hemophilia A and B who have undergone coronary artery bypass surgery. High levels of replacement therapy with factor concentrate either with bolus or continuous infusion are usually required pre‐operatively and during the first post‐operative days in order to maintain the coagulation deficient factor levels greater than 80% of normal. Heparinization during cardiopulmonary bypass appears to be safe and intra‐operative blood salvage using cell saver techniques reduce the need for transfusions.
机译:摘要只有少数患者血友病A和B的患者,谁经历了冠状动脉旁路手术。 具有因子浓缩的高水平的替代疗法,其具有推注或连续输注通常是预先操作性的,并且在第一个操作时间内需要进行,以保持凝血缺陷的因子水平大于正常的80%。 在心肺期间肝素化似乎是使用细胞节省技术的安全和术中血液抢购,这减少了输血的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号